{
  "CitationSubset": [],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "8111439",
  "DateCompleted": {
    "Year": "1994",
    "Month": "03",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "12",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1065-4704",
      "JournalIssue": {
        "Volume": "1",
        "Issue": "4",
        "PubDate": {
          "Year": "1993",
          "Season": "Nov-Dec"
        }
      },
      "Title": "Cancer practice",
      "ISOAbbreviation": "Cancer Pract"
    },
    "ArticleTitle": "Drug therapy management of the febrile neutropenic cancer patient.",
    "Pagination": {
      "StartPage": "295",
      "EndPage": "304",
      "MedlinePgn": "295-304"
    },
    "Abstract": {
      "AbstractText": [
        "Neutropenia is one of the major dose-limiting toxicities of cancer chemotherapy. Since the 1960s, dramatic changes have occurred in its epidemiology, microbiology, and treatment. This article highlights these important changes; reviews the history and current practice of antibiotic, antifungal, and antiviral therapy; and looks toward future therapy using colony-stimulating factors (CSFs) for the infectious complications in the febrile neutropenic cancer patient."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Finkbiner",
        "ForeName": "K L",
        "Initials": "KL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ernst",
        "ForeName": "T F",
        "Initials": "TF"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Pract",
    "NlmUniqueID": "9312355",
    "ISSNLinking": "1065-4704"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Colony-Stimulating Factors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Colony-Stimulating Factors"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "microbiology"
      ],
      "DescriptorName": "Infections"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Neutropenia"
    }
  ],
  "NumberOfReferences": "97"
}